R. Menendez Villanueva (Valencia, Spain), C. Luna (Buenos Aires, Argentina), E. Van De Garde (Nieuwegein, Netherlands)
Respiratory viral infections in adult asthma exacerbation:one year survey at a Japanese university hospital for characterization of hospitalized or not hospitalized patients
T. Saraya, D. Kurai, H. Tsukagoshi, H. Ishii, H. Kimura, H. Goto, H. Takizawa (Mitaka, Maebashi, Musashimurayama, Japan)
|   |
Clinical characteristics of chronic pulmonary aspergillosis and colonization; retrospective analysis of patients with isolation of asperguillus species from respiratory samples
S. Ohara, Y. Tazawa, H. Horiuchi, K. Usui (Tokyo, Japan)
| |
Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases
M. Díez-Ferrer, Y. Ruiz, C. Ardanuy, F. Tubau, J. Camara, J. Dorca (Hospitalet de Llobregat, Spain)
| |
Influenza but not rhinovirus viral strain causes exacerbation of a house dust mite driven severe asthma mouse model
J. De Alba, E. Calama, R. Otal, F. Gil, M. Miralpeix, On Behalf of the U-BIOPRED Study (Barcelona, Spain)
| |
The outcome of community-acquired pneumonia in patients with COPD, asthma and ILD - a case-control study
F. Dusemund, J. Chronis, F. Baty, W. Albrich, M. Brutsche (St. Gallen, Switzerland)
| |
Incidence and outcomes of hospitalized for COPD exacerbations with and without pneumonia, 2006-2012: A nationwide cohort study
M. Søgaard, M. Madsen, A. Løkke, O. Hilberg, A. G. Jensen, J. Dollerup, R. W. Thomsen (Aarhus, Ballerup, Brønby, Denmark)
| |
Patients with no cystic fibrosis bronchiectasis colonized by pseudomonas aeruginosa: Role of inhaled colistin
A. Trujillano Ruiz, M. J. Avilés Inglés, M. T. Antequera Lardón, J. J. Franco Miguel, M. C. Abellán Martínez, P. Méndez Martínez, J. C. Vicente López (Murcia, Spain)
| |
Direct LAMP assay from clinical sample for carbapenem resistant A. baumannii
S. Hamaguchi, N. Yamamoto, Y. Akeda, P. Santanirand, A. Kerdsin, M. Seki, W. Phang, K. Malathum, K. Oishi, K. Tomono (Osaka, Tokyo, Japan; Bangkok, Thailand)
| |
Community adquired legionella pneumophila pneumonia in elderly patients
L. A. Ruiz, S. Castro, A. Gómez, A. Sagarna, E. Pérez, E. Urra, A. Urrutia, R. Diez, R. Zalacain (Barakaldo, Spain)
| |
Pseudomonas, enterobacteriaceae ESBL positive and staphylococcus MRSA: When to suspect them in CAP?
E. Prina, O. T. Ranzani, E. Polverino, C. Cillóniz, M. Ferrer, L. Fernandez, J. Puig de la Bellacasa, R. Menéndez, J. Mensa, A. Torres (Barcelona, Valencia, Spain; São Paulo, Brazil)
| |
Microbial aetiology of community-acquired pneumonia and it's relation with ICS use in patients with COPD – Results from the German competence network CAPNETZ
D. Braeken, F. Franssen, H. Schütte, M. Pletz, R. Bals, P. Martus, G. Rohde (Horn, Maastricht, Berlin, Netherlands; Jena, Homburg, Tübingen, Hannover, Germany)
| |
In-hospital mortality risk assessment in patients with community acquired pneumonia
V. Kostadinova, D. Miteva, Y. Radkov, I. Mircheva (Varna, Bulgaria)
| |
Can the broad-spectrum antibiotics improve the prognoses of high-risk nursing- and healthcare-associated pneumonia?
K. Umeki, K. Komiya, E. Mizukami, H. Kushima, S. Toba, M. Ando, S. Nureki, I. Tokimatsu, K. Hiramatsu, J. Kadota (Yufu, Oita, Japan)
| |
Comparison of the prognostic value of different severity scales in community- acquired pneumonia
D. Miteva, V. Kostadinova, Y. Radkov, I. Mircheva (Varna, Bulgaria)
| |
Possible role of anaerobes in the progression of nontuberculous mycobacteriosis
K. Yamasaki, K. Yatera, T. Kawanami, K. Akata, S. Noguchi, C. Nishida, H. Ishimoto, K. Fukuda, H. Taniguchi, H. Mukae (Kitakyushu, Japan)
| |
Assessing decision of inpatient or outpatient care in community acquired pneumonia patients: Results of APT care study
S. Ullah, J. A. Khan, A. Khan, I. Hashemy (Karachi, Pakistan)
| |
Nursing and healthcare-associated pneumonia requiring hospital admission: Microbiology and clinical outcomes
N. Mamesaya, H. Tomioka, S. Nakao, R. Sekiya, S. Yamashita, T. Kaneda, Y. Kida, C. Nishio, M. Kaneko (Kobe, Japan)
| |
Nontuberculous mycobacteria lung infection in bronchiectasis: Prevalence and clinical characteristics
J. F. Xu, X. B. Ji, L. C. Fan, H. P. Xiao, H. W. Lu (Shanghai, China)
| |
Comparative analysis of the predictive utility of clinical disease severity scores for non-cystic fibrosis bronchiectasis
M. McDonnell, P. Goeminne, S. Alberti, J. Davison, S. Lonni, L. Poppelwell, W. Salih, A. Pesci, T. Fardon, L. Dupont, A. Hill, A. De Soyza, J. Chalmers (Newcastle, Edinburgh, Dundee, United Kingdom; Galway, Ireland; Leuven, Belgium; Monza, Italy)
| |
Relationship between procacitonin and C-reactive protein and sputum culture results in patients with acute excecerbation of COPD
H. Tanriverdi, M. M. Tor, F. Atalay, T. Örnek, B. Altinsoy, F. Erboy, F. Uygur (Zonguldak, Turkey)
| |